Registration for the ASCP 2021 Annual Meeting is now open. The meeting will be held virtually on June 1-4, 2021. Join us as we present Integrating New & Novel Treatments Into Clinical Practice & Education. Click here to register.
You are invited to participate in the 2021 Annual Meeting of the American Society of Clinical Psychopharmacology (ASCP) by submitting a proposal. The committee welcomes submissions from the U.S. as well as International proposals. Click here for more information.
Join ASCP today and become part of an organization dedicated to advance the science and practice of clinical psychopharmacology. Members benefits from discounted registration to ASCP’s Annual Meeting, Psychopharmacology Update and Clinical Trials Workshop.
The ASCP Annual Meeting is the premiere meeting each year in the field of psychopharmacology. Bringing together representatives from academia, the National Institutes of Health (NIH), Food and Drug Administration (FDA), European regulatory agencies and industry to discuss key aspects of neuropsychiatric drug development, including the impact of diagnostic changes and personalized interventions based on biomarkers or genetic information. A Steering Committee chaired by Drs. Susan Kornstein and Mark Rapaport with representation of the sectors that are part of the ASCP community lead the direction of the meeting. Representatives from the FDA, EMA, NIMH, NIDA, NIAAA, the pharmaceutical industry and academia comprise the 2021 Steering Committee. A Program Committee under the leadership of Drs. Erika Saunders and Lee Cohen are responsible for the review of all program submissions.
